| human | Q5 |
| P269 | IdRef ID | 110977890 |
| P8189 | J9U ID | 987007454079405171 |
| P1368 | National Library of Latvia ID | 000057464 |
| P1207 | NUKAT ID | n2014121956 |
| P214 | VIAF cluster ID | 4014139 |
| P8413 | academic appointment | Vanderbilt Department of Medicine | Q89953931 |
| P1416 | affiliation | Nashville Symphony | Q6967018 |
| P1343 | described by source | Giants in Chest Medicine: Arthur P. Wheeler, MD, FCCP | Q89392408 |
| P69 | educated at | University of Maryland | Q503415 |
| P108 | employer | Vanderbilt University | Q29052 |
| P734 | family name | Wheeler | Q13400757 |
| P101 | field of work | medical education | Q126945 |
| pulmonology | Q203337 | ||
| airway management | Q286949 | ||
| acute respiratory distress syndrome | Q344873 | ||
| intensive care medicine | Q679690 | ||
| mechanical ventilation | Q3766250 | ||
| nurse education | Q13378080 | ||
| P735 | given name | Arthur | Q1778168 |
| Arthur | Q1778168 | ||
| P106 | occupation | physician | Q39631 |
| university teacher | Q1622272 | ||
| medical researcher | Q15401884 | ||
| pulmonologist | Q24017632 | ||
| P21 | sex or gender | male | Q6581097 |
| Q33783273 | A randomized trial comparing didactics, demonstration, and simulation for teaching teamwork to medical residents |
| Q34442440 | A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury |
| Q43012266 | A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis |
| Q38458840 | A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: comparison with a controlled clinical trial |
| Q36812654 | Acute lung injury and the acute respiratory distress syndrome: a clinical review |
| Q24620461 | Acute respiratory distress syndrome, sepsis, and cognitive decline: a review and case study |
| Q50726565 | Addition of acute care nurse practitioners to medical and surgical rapid response teams: a pilot project |
| Q44190537 | Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury |
| Q27318092 | An Electronic Tool for the Evaluation and Treatment of Sepsis in the ICU: A Randomized Controlled Trial |
| Q38010417 | An Official Multi-Society Statement: The Role of Clinical Research Results in the Practice of Critical Care Medicine |
| Q37383112 | Approach to the patient with sepsis |
| Q33304458 | Approaching and analyzing a large literature on vancomycin monitoring and pharmacokinetics |
| Q37166377 | B-Type Natriuretic Peptide, Aldosterone, and Fluid Management in ARDS. |
| Q87306917 | Central venous catheter insertion by advanced practice nurses: another demonstrated competency* |
| Q64132550 | Chlorhexidine Bathing and Infections in Critically Ill Patients—Reply |
| Q35247984 | Chlorhexidine bathing and health care-associated infections: a randomized clinical trial |
| Q33387419 | Coagulopathy in critically ill patients: part 1: platelet disorders |
| Q37668852 | Coagulopathy in critically ill patients: part 2-soluble clotting factors and hemostatic testing |
| Q51912384 | Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. |
| Q34528886 | Comparison of two fluid-management strategies in acute lung injury |
| Q44919440 | Deviations from evidence-based clinical management guidelines increase mortality in critically injured trauma patients*. |
| Q47686717 | Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock |
| Q30417223 | Enteral Omega-3 Fatty Acid, γ-Linolenic Acid, and Antioxidant Supplementation in Acute Lung Injury |
| Q47364711 | Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis |
| Q86759801 | Fosfomycin for multidrug treatment of Klebsiella pneumoniae carbapenemase bacteremia |
| Q36689466 | Impact of Initial Central Venous Pressure on Outcomes of Conservative Versus Liberal Fluid Management in Acute Respiratory Distress Syndrome |
| Q39749669 | Implementation of a Medical Intensive Care Unit Acute-Care Nurse Practitioner Service |
| Q39535175 | Incidence and characterization of acute kidney injury after acetaminophen overdose |
| Q30417667 | Initial Trophic vs Full Enteral Feeding in Patients With Acute Lung Injury: The EDEN Randomized Trial |
| Q33752473 | Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis |
| Q45220170 | Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury |
| Q43160112 | Macrolides for Acute Lung Injury |
| Q37053023 | Markers of inflammation and coagulation may be modulated by enteral feeding strategy |
| Q87096752 | Mechanical Ventilation, Clinical Trials, and Glaciers |
| Q38702429 | Medication Desensitization: Characterization of Outcomes and Risk Factors for Reactions |
| Q44473697 | Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). |
| Q37094662 | Outcomes of Nurse Practitioner-Delivered Critical Care: A Prospective Cohort Study |
| Q41021118 | Pharmacist leadership in ICU quality improvement: coordinating spontaneous awakening and breathing trials |
| Q35801043 | Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. |
| Q64132581 | Promoting adherence to ventilator management and ventilator weaning protocols |
| Q34528894 | Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. |
| Q30437457 | Racial and ethnic disparities in mortality from acute lung injury |
| Q35671060 | Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*. |
| Q35007473 | Randomized trial of initial trophic versus full-energy enteral nutrition in mechanically ventilated patients with acute respiratory failure |
| Q37031773 | Recent developments in the diagnosis and management of severe sepsis |
| Q77450928 | Recovery Rate and Prognosis in Older Persons Who Develop Acute Lung Injury and the Acute Respiratory Distress Syndrome |
| Q35069842 | Remote source document verification in two national clinical trials networks: a pilot study |
| Q36411339 | Response to fluid boluses in the fluid and catheter treatment trial |
| Q64132590 | Safety and efficacy of affinity-purified, anti–tumor necrosis factor-α, ovine fab for injection (CytoFab) in severe sepsis* |
| Q42352892 | Size and How You Measure It Matters |
| Q87059740 | Slow and Study: Support for a Randomized Trial of β-Blockade in Sepsis-Associated Atrial Fibrillation |
| Q88007748 | Systemic inflammatory response syndrome after cardiac surgery: time for a change |
| Q33980044 | The Effect of Pulmonary Artery Catheter Use on Costs and Long-Term Outcomes of Acute Lung Injury |
| Q37699533 | Thrombotic risk and immobility in residents of long-term care facilities |
| Q37396389 | Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders |
| Q41151944 | Understanding chlorhexidine decolonization strategies |
| Q34999600 | Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis |
| Q47775323 | Variation in enteral nutrition delivery in mechanically ventilated patients |
| Q35559405 | Vascular pedicle width in acute lung injury: correlation with intravascular pressures and ability to discriminate fluid status |
| Q36499134 | Venous thromboembolism in medically ill patients: identifying risk and strategies for prevention |
| Q89392408 | Giants in Chest Medicine: Arthur P. Wheeler, MD, FCCP | main subject | P921 |
Search more.